Covered recipient · General Payments record
HEATHER L WAGNER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,564.04
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $671.67 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $357.79 | 9 |
| REVANCE THERAPEUTICS, INC. | $214.32 | 7 |
| Galderma Laboratories, L.P. | $82.99 | 1 |
| Exeltis, USA Inc. | $16.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $141.97 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368723 | CMS |
| ABBVIE INC. | $14.37 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368725 | CMS |
| ABBVIE INC. | $20.82 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368727 | CMS |
| ABBVIE INC. | $29.67 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368729 | CMS |
| ABBVIE INC. | $11.91 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368731 | CMS |
| ABBVIE INC. | $22.83 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368733 | CMS |
| ABBVIE INC. | $94.72 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368735 | CMS |
| ABBVIE INC. | $17.01 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368737 | CMS |
| ABBVIE INC. | $4.49 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108368739 | CMS |
| Exeltis, USA Inc. | $16.57 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150021051 | CMS |
| Galderma Laboratories, L.P. | $82.99 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145398982 | CMS |
| REVANCE THERAPEUTICS, INC. | $14.85 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953132 | CMS |
| REVANCE THERAPEUTICS, INC. | $26.42 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953134 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.74 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953136 | CMS |
| REVANCE THERAPEUTICS, INC. | $60.00 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953138 | CMS |
| REVANCE THERAPEUTICS, INC. | $27.88 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953140 | CMS |
| REVANCE THERAPEUTICS, INC. | $27.88 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953142 | CMS |
| REVANCE THERAPEUTICS, INC. | $24.55 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953144 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.